Citroma Liquid
FDA Recall NDC 55910-183
FDA Enforcement Report: View Recall Date, Reasons, and Safety Status
Active & Historical Enforcement Reports
The FDA has identified 1 recorded enforcement report(s) associated with Citroma (NDC 55910-183). A significant event, classified as Class I, was initiated on Jul 15, 2022 by Old East Main Co.. The reported reason for this action was: "Microbial contamination of non-sterile products."
This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.
This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.
Reported Recall Events
July 2022 Class I Recall: Microbial contamination of non-sterile products.
Recall Number
Class I Terminated
Microbial contamination of non-sterile products.
Jul 15, 2022
Sep 21, 2022
42,912 bottles
Recall Profile & Regulatory Data
Event ID
90599
Classification
Class I
Enforcement Status
Terminated
Recalling Firm
Vi-Jon, LLC
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
Distributed Nationwide in the USA as well as Canada and Panama.
Termination Date
May 09, 2024
Product Description
Rexall, Magnesium Citrate Saline Laxative, Oral Solution, (1.745 g/fl oz), Lemon Flavor, 10 FL OZ (296 mL), Distributed By Dolgencorp. LLC 100 Mission Ridge, Goodlettsville, TN 37072 or Distributed By Old East Main Co. 100 Mission Ridge Goodlettsville, TN 37072; NDC 55910-183-38, UPC 0 72785 13418 8
Batch or Lot Expiration Information
Lot# 0511629, EXP 12/4/2022; 0562243, EXP 2/17/2024
Affected Packages Involved in this Recall
55910-183-38Product
About FDA Recall Enforcement Reports
FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.
If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.
